Erratum to: Curr Allergy Asthma Rep (2015) 15: 36
DOI 10.1007/s11882-015-0539-8
In the original version of this article the Conflict of Interest statement contains a mistake. The correct statement should have read as follows:
Conflict of Interest Martin D. Chapman declares that he is a founder and co-owner of Indoor Biotechnologies. Sabina Wuenschmann, Eva King, and Anna Pomés declare that they are employees of Indoor Biotechnologies.
Author information
Authors and Affiliations
Corresponding author
Additional information
The online version of the original article can be found at http://dx.doi.org/10.1007/s11882-015-0539-8.
Rights and permissions
About this article
Cite this article
Chapman, M.D., Wuenschmann, S., King, E. et al. Erratum to: Technological Innovations for High-Throughput Approaches to In Vitro Allergy Diagnosis. Curr Allergy Asthma Rep 15, 52 (2015). https://doi.org/10.1007/s11882-015-0559-4
Published:
DOI: https://doi.org/10.1007/s11882-015-0559-4